Hydroxychloroquine is promising for neuroprotection in primary progressive MS: an open label, single arm, Phase II futility trialM. Koch, S. Kaur,K. Sage,J. Kim, M. Levesque-Roy, G. Cerchiaro,V. W. Yong,G. Cutter,L. MetzMULTIPLE SCLEROSIS JOURNAL(2021)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要